|4Jan 20, 9:32 PM ET

ALTOMARI ALFRED 4

4 · AGILE THERAPEUTICS INC · Filed Jan 20, 2022

Insider Transaction Report

Form 4
Period: 2022-01-19
ALTOMARI ALFRED
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-01-19+675,000675,000 total
    Exercise: $0.34Exp: 2032-01-18Common Stock (675,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 19, 2026.

Documents

1 file
  • 4
    tm224102-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT